(Q45953122)

18 December 2017

title

HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival. (English)

1 reference

18 December 2017

1 reference

ovarian serous carcinoma

1 reference

Helene Tuft Stavnes

1

1 reference

18 December 2017

Arild Holth

2

1 reference

18 December 2017

Trinh Don

3

1 reference

18 December 2017

Janne Kærn

4

1 reference

18 December 2017

Olga Vaksman

5

1 reference

18 December 2017

Reuven Reich

6

1 reference

18 December 2017

Claes G Trope'

7

1 reference

18 December 2017

Ben Davidson

8

1 reference

18 December 2017

language of work or name

English

0 references

publication date

21 February 2013

1 reference

18 December 2017

published in

Gynecologic Oncology

1 reference

18 December 2017

volume

129

1 reference

18 December 2017

issue

2

1 reference

18 December 2017

page(s)

358-363

1 reference

18 December 2017

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

Neoadjuvant chemotherapy, interval debulking surgery or primary surgery in ovarian carcinoma FIGO stage IV?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

The pathophysiology of HOX genes and their role in cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

The Hox genes and their roles in oncogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

HOX genes in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

Aberrant expression of homeobox gene HOXA7 is associated with müllerian-like differentiation of epithelial ovarian tumors and the generation of a specific autologous antibody response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

WT1 represses HOX gene expression in the regulation of gynaecologic tumour histologic type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

Cell motility and spreading are suppressed by HOXA4 in ovarian cancer cells: possible involvement of beta1 integrin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

HOXA10 is overexpressed in human ovarian clear cell adenocarcinoma and correlates with poor survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

HOXB13 promotes ovarian cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical features.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

HOXA11 DNA methylation--a novel prognostic biomarker in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

Gene Expression Patterns in Ependymomas Correlate with Tumor Location, Grade, and Patient Age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

Evidence for a functional role of epigenetically regulated midcluster HOXB genes in the development of Barrett esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

A microRNA-7 binding site polymorphism in HOXB5 leads to differential gene expression in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

HoxB5 is an upstream transcriptional switch for differentiation of the vascular endothelium from precursor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

Human colorectal carcinogenesis is associated with deregulation of homeobox gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

Inhibition of myeloid differentiation by Hoxa9, Hoxb8, and Meis homeobox genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

Antagonism of HOX/PBX dimer formation blocks the in vivo proliferation of melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

Targeting the HOX/PBX dimer in breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

Targeting HOX and PBX transcription factors in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.021

10.1016/J.YGYNO.2013.02.021

7 January 2021

Identifiers

DOI

1 reference

18 December 2017

release_ekka4b7agvenrbb7etsh56az54

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ekka4b7agvenrbb7etsh56az54

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

18 December 2017